BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 5 hits Enz. Inhib. hit(s) with Target = 'Muscarinic acetylcholine receptor M3' and Ligand = 'BDBM325607'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM325607
PNG
(US9636336, Example 18 | US9636336, Example 77 | US...)
Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC(C(=O)OC[C@H]2CCN(C)C2)c2ccccc2)s1
Show InChI InChI=1S/C35H37Cl2N3O7S/c1-39-14-13-22(18-39)21-46-35(42)33(23-7-5-4-6-8-23)38-17-25-10-12-32(48-25)34(41)47-30(16-26-27(36)19-40(43)20-28(26)37)24-9-11-29(44-2)31(15-24)45-3/h4-12,15,19-20,22,30,33,38H,13-14,16-18,21H2,1-3H3/t22-,30-,33?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.590n/an/an/an/an/an/an/an/a



CHIESI FARMACEUTICI S.p.A.

US Patent


Assay Description
Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...


US Patent US9636336 (2017)

More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM325607
PNG
(US9636336, Example 18 | US9636336, Example 77 | US...)
Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC(C(=O)OC[C@H]2CCN(C)C2)c2ccccc2)s1
Show InChI InChI=1S/C35H37Cl2N3O7S/c1-39-14-13-22(18-39)21-46-35(42)33(23-7-5-4-6-8-23)38-17-25-10-12-32(48-25)34(41)47-30(16-26-27(36)19-40(43)20-28(26)37)24-9-11-29(44-2)31(15-24)45-3/h4-12,15,19-20,22,30,33,38H,13-14,16-18,21H2,1-3H3/t22-,30-,33?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.19n/an/an/an/an/an/a



CHIESI FARMACEUTICI S.p.A.

US Patent


Assay Description
Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...


US Patent US9636336 (2017)

More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM325607
PNG
(US9636336, Example 18 | US9636336, Example 77 | US...)
Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC(C(=O)OC[C@H]2CCN(C)C2)c2ccccc2)s1
Show InChI InChI=1S/C35H37Cl2N3O7S/c1-39-14-13-22(18-39)21-46-35(42)33(23-7-5-4-6-8-23)38-17-25-10-12-32(48-25)34(41)47-30(16-26-27(36)19-40(43)20-28(26)37)24-9-11-29(44-2)31(15-24)45-3/h4-12,15,19-20,22,30,33,38H,13-14,16-18,21H2,1-3H3/t22-,30-,33?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.5n/an/an/an/an/an/a



CHIESI FARMACEUTICI S.p.A.

US Patent


Assay Description
Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...


US Patent US9636336 (2017)

More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM325607
PNG
(US9636336, Example 18 | US9636336, Example 77 | US...)
Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC(C(=O)OC[C@H]2CCN(C)C2)c2ccccc2)s1
Show InChI InChI=1S/C35H37Cl2N3O7S/c1-39-14-13-22(18-39)21-46-35(42)33(23-7-5-4-6-8-23)38-17-25-10-12-32(48-25)34(41)47-30(16-26-27(36)19-40(43)20-28(26)37)24-9-11-29(44-2)31(15-24)45-3/h4-12,15,19-20,22,30,33,38H,13-14,16-18,21H2,1-3H3/t22-,30-,33?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.5n/an/an/an/an/an/a



CHIESI FARMACEUTICI S.p.A.

US Patent


Assay Description
Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...


US Patent US9636336 (2017)

More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM325607
PNG
(US9636336, Example 18 | US9636336, Example 77 | US...)
Show SMILES COc1ccc(cc1OC)[C@H](Cc1c(Cl)c[n+]([O-])cc1Cl)OC(=O)c1ccc(CNC(C(=O)OC[C@H]2CCN(C)C2)c2ccccc2)s1
Show InChI InChI=1S/C35H37Cl2N3O7S/c1-39-14-13-22(18-39)21-46-35(42)33(23-7-5-4-6-8-23)38-17-25-10-12-32(48-25)34(41)47-30(16-26-27(36)19-40(43)20-28(26)37)24-9-11-29(44-2)31(15-24)45-3/h4-12,15,19-20,22,30,33,38H,13-14,16-18,21H2,1-3H3/t22-,30-,33?/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



CHIESI FARMACEUTICI S.p.A.

US Patent


Assay Description
Human M3 receptor membranes (15 μg/well) from Perkin Elmer are incubated with 0.52 nM Scopolamine Methyl Chloride, [N-methyl-3H] with or without...


US Patent US9636336 (2017)

More data for this
Ligand-Target Pair